Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model
Open Access
- 1 July 2008
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (5) , 958-970
Abstract
Background and purpose: Bradycardia is a risk factor for the development of torsade de pointes (TdP). The aim of this work was to compare the importance of changes in heart rate and arterial blood pressure in the development of drug‐induced TdP and to investigate the role of vagal influences.Experimental approach: Experiments were performed in open‐chest, pentobarbital‐anaesthetized, male rabbits which were given clofilium (20, 60 and 200 nmol kg−1 min−1) with rising doses of either phenylephrine (75, 150, 225 and 300 nmol kg−1 min−1), angiotensin II (0.25, 0.5, 0.75 and 1 nmol kg−1 min−1) or saline. A fourth group received phenylephrine and cloflium after bilateral vagotomy. ECGs, haemodynamics and epicardial monophasic action potentials were recorded.Key results: TdP occurred in 57% of rabbits given phenylephrine and clofilium. Replacement of phenylephrine with saline or angiotensin II reduced the incidence of TdP to 0 and 17%, respectively. Vagotomy prevented TdP in rabbits given phenylephrine and clofilium. Increases in blood pressure induced by phenylephrine and angiotensin II were similar. Bradycardia only occurred with phenylephrine and was reduced but not abolished by vagotomy. Neither short‐term variability of repolarization nor action potential triangulation could predict TdP.Conclusions and implications: These results indicate that reflex activation of vagal nerve activity is essential for the induction of drug‐induced TdP in α1‐adrenoceptor‐stimulated anaesthetized rabbits. This implies that alterations in vagal activity may also precipitate episodes of drug‐induced TdP in man and that this should be considered in selecting models used in drug development.British Journal of Pharmacology (2008) 154, 958–970; doi:10.1038/bjp.2008.154; published online 21 April 2008Keywords
This publication has 59 references indexed in Scilit:
- Relevance of anaesthesia for dofetilide-induced torsades de pointes in α1 -adrenoceptor-stimulated rabbitsBritish Journal of Pharmacology, 2008
- Potentiation of E‐4031‐induced torsade de pointes by HMR1556 or ATX‐II is not predicted by action potential short‐term variability or triangulationBritish Journal of Pharmacology, 2007
- Combined pharmacological block of IKr and IKs increases short‐term QT interval variability and provokes torsades de pointesBritish Journal of Pharmacology, 2007
- Autonomic Nerve Stimulation Reverses Ventricular Repolarization Sequence in Rabbit HeartsCirculation Research, 2007
- Comparison of the In Vitro Electrophysiologic and Proarrhythmic Effects of Amiodarone and Sotalol in a Rabbit Model of Acute Atrioventricular BlockJournal of Cardiovascular Pharmacology, 2004
- Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointesBritish Journal of Pharmacology, 2002
- Proarrhythmia of Azimilide and Other Class III Antiarrhythmic Agents in the Adrenergically Stimulated RabbitProceedings of the Society for Experimental Biology and Medicine, 2000
- Acetylcholine-lnduced prolongation of the qt interval in idiopathic long qt syndromeThe American Journal of Cardiology, 1996
- Angiotensin II exerts differential actions on renal nerve activity and heart rate.Hypertension, 1994
- RELATIVE CONTRIBUTIONS OF VAGAL AND CARDIAC SYMPATHETIC NERVES TO THE REFLEX BRADYCARDIA INDUCED BY A PRESSOR STIMULUS IN THE CONSCIOUS RABBIT: COMPARISON OF ‘STEADY STATE’ AND ‘RAMP’ METHODSClinical and Experimental Pharmacology and Physiology, 1984